Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 26, Issue 3, 2005, Pages 157-162

  Murry, Thomas ^a   Wasserman, Tamara ^b   Carrau, Ricardo L ^b   Castillo, Beatriz ^b  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; AGED; ARTICLE; ASPIRATION; CLINICAL ARTICLE; CRICOID; DIET THERAPY; DYSPHAGIA; ELECTROMYOGRAM; ESOPHAGUS DISEASE; FEMALE; HUMAN; MALE; NUTRITIONAL STATUS; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; RISK FACTOR; SAFETY; SWALLOWING; TREATMENT OUTCOME; UPPER ESOPHAGUS SPHINCTER; INJECTION; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; PROSPECTIVE STUDY;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; DEGLUTITION DISORDERS; ESOPHAGEAL DISEASES; ESOPHAGEAL SPHINCTER, UPPER; FEMALE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES;

EID: 24044471344     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2004.11.010     Document Type: Article

References (17)

1. Woodson GA. Cricopharyngeal myotomy and arytenoids adduction in the management of combined laryngeal and pharyngeal paralysis. Otolaryngol Head Neck Surg 1997;116(3):339-43.
2. Shapiro J, Kelley JK. Anatomy, histology and clinical dysfunction of the cricopharyngeus muscle. Head Neck Surg 1994;2:52-4.
3. Singer MI, Blom ED, Hamaker RC. Pharyngeal plexus neurectomy for alaryngeal speech rehabilitation. Laryngoscope 1986;96(1):50-4.
4. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Opthalmology 1980;87:1044-9.
5. Jancovic J, Hallet M, editors. Therapy with botulinum toxin. New York: Marcel Decker, Inc; 1994.
6. Schneider J, Tjumfard W, Potoschnig C, et al. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: injection of a new non invasive method. Ann Otol Rhinol Laryngol 1994;103:31-5.
7. Blitzer A, Brin MF. Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol Head Neck Surg 1997;116(3):328-30.
8. Ahsan SF, Meleca RJ, Dworkin JP. Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia. Otolaryngol Head Neck Surg 2000;122(5):691-5.
9. Dunne J, Hayes M, Cameron D. Botulinum toxin A for cricopharyngeal dystonia. Lancet 1998;342(8870):359.
10. Atkinson SI, Rees J. Botulinum toxin for cricopharyngeal dysphagia: case reports of CT guided injection. J Otolaryngol 1997;26(4):273-6.
11. Haapanieme JJ, Laurikainen EA, Pulkkinen J, et al. Botulinum toxin in the treatment of cricopharyngeal dysphagia. Dysphagia 2001;16: 171-5.
12. Shaw GY, Searl JP. Botulinum toxin treatment for cricopharyngeal dysfunction. Dysphagia 2001;16:161-7.
13. Alberti J, Oelerich M, Ludwig K. Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction. Laryngoscope 2000;110:1151-6.
14. Rosenbek JC, Robbins JA, Poeckeer EB, et al. A penetration-aspiration scale. Dysphagia 1996;11:93-8.
15. Coton T. Statistics in medicine. Boston: Little Brown and Co; 1974. p. 189-219.
16. Murry T, Carrau RL. Clinical manual for swallowing disorders. San Diego: Singular Thompson Learning; 2001. p. 113-34.
17. Ravich WJ. Botulinum toxin for UES dysfunction: therapy or poison? Dysphagia 2001;16:168-70.